| Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors (NCT05416359) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-06-01 |
| Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors (NCT05198505) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2022-04-27 |
| A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor (NCT05089461) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-03-07 |
| A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors (NCT04975204) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-02-18 |
| BAT7104 Injection in Patients With Advanced Malignant Tumors. (NCT05767060) | Bio-Thera Solutions | 2022-01-20 |
| A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors (NCT05144061) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-12-20 |
| Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies (NCT05042908) | Nanjing Leads Biolabs Co.,Ltd | 2021-12-02 |
| Phase I/II Clinical Trial of LBL-015 for Injection (NCT05107011) | Nanjing Leads Biolabs Co.,Ltd | 2021-11-08 |
| A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor (NCT05015309) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2021-09-01 |
| A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies (NCT04954456) | Qilu Pharmaceutical Co., Ltd. | 2021-06-02 |
| An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor (NCT04739111) | Dragonboat Biopharmaceutical Company Limited | 2021-01-29 |
| A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor (NCT04412564) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-08-05 |
| QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors (NCT04326829) | Qilu Pharmaceutical Co., Ltd. | 2020-07-08 |
| A Study of QL1706 in Subjects With Advanced Malignant Tumor (NCT04296994) | Qilu Pharmaceutical Co., Ltd. | 2020-03-31 |